BioNTech’s CAR T-cell Therapy, Accompanying Vaccine Demonstrate High Anti-tumor Activity in Solid Tumors, Mouse Study Shows
News
Claudin 6, a cell surface protein involved in cell junction formation, may be a promising target for CAR T-cell therapies against solid tumors, according to a proof-of-concept study in mice. ... Read more